CD38 and B-cell chronic lymphocytic leukemia: To compare the impact of the elevated CD38 expression and extracellular ADO production on the PD-1/PD-L1 axis between the CLL and B-NHL group, our study revealed a higher sPD-L1 level in the CLL vs. B-NHL group.